Key facts
Global business
Updated November 2024
Chief Executive Officer:
Headquarters:
Princeton, New Jersey, USA
Business:
Biopharmaceuticals
Web address:
NYSE listing:
BMY
Net global sales:
$45 billion (2023)
R&D investment:
$9.3 billion (2023), including the discovery and development of new drugs for patients
Principal locations:
Local business
Updated November 2024
BMS India:
Commercial operations
BMS Hyderabad (business insights and technology; drug development; enabling functions)
Biocon BMS Research & Development Center (BBRC)
BMS Hyderabad (business insights and technology; drug development; enabling functions)
Biocon BMS Research & Development Center (BBRC)
Business:
Biopharmaceuticals, research operations, business services
Leadership:
Sanjay Sharma - BMS Commercial operations (Mumbai)
Mohit Dhingra - BMS (Hyderabad)
Mohit Dhingra - BMS (Hyderabad)
Locations:
Mumbai, Hyderabad, Bangalore
Key therapeutic areas:
Oncology
Hematology
Cardiovascular
Immunology
Hematology
Cardiovascular
Immunology
NO-IN-2400012
Expiry: 14 Nov. 2026